Patients may begin to see benefits after four weeks, but the full effects typically become evident after several months of continued use
Table 1: Patient demographics Reasons for discontinuation Across the entire population, side effects were the leading reason patients stopped taking GLP-1 RAs, accounting for 28.2% of all discontinuations (Table 2)
Diagnostic Tests Physical exam: To check an enlarged thyroid, pulse, and other physical signs
Do I need a diagnosis besides obesity
Reduced Inflammation Research demonstrates BPC-157 modulates inflammatory pathways, reducing levels of pro-inflammatory cytokines while promoting anti-inflammatory responses
Both medications are effective weight loss tools, but they function in slightly different ways: Semaglutide targets the GLP-1 receptor, mimicking the GLP-1 hormone to reduce appetite, slow digestion, and control blood sugar